Editas Medicine, Inc. EDIT
Set alert
2.57 USD -0.10 -3.75%
At close
2.74 +0.17 +6.58%
Pre-market · Nov 3, 8:38 AM ET
2.55 Day range 2.78
1.66 52-week range 3.94
- YTD
- +25.37%
- 1 year
- -16.01%
- Open
- 2.71
- Prev close
- 2.67
- Mkt cap
- 394.70M
- Vol
- 1.24M
- Avg vol
- 2.69M
- EPS
- -0.68
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.55
- High
- 2.78
- Forward P/E
- -0.53
- Beta
- 2.01
- Short ratio
- 6.70
- Inst. own
- 70.94%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.60
- 200-d avg
- 4.55
- 1y target
- 3.67
1D chart
Signals (31)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | 3:58 PM | 16 hours ago |
| MACD: Buy Signal | 3:50 PM | 17 hours ago |
| RSI: Oversold | 3:43 PM | 17 hours ago |
| MACD: Sell Signal | 3:26 PM | 17 hours ago |
| MACD: Buy Signal | 2:51 PM | 18 hours ago |
| MACD: Sell Signal | 2:50 PM | 18 hours ago |
| MACD: Buy Signal | 2:46 PM | 18 hours ago |
| RSI: Oversold | 2:41 PM | 18 hours ago |
| MACD: Sell Signal | 2:32 PM | 18 hours ago |
| MACD: Buy Signal | 2:06 PM | 18 hours ago |
| RSI: Oversold | 1:53 PM | 19 hours ago |
| RSI: Oversold | 1:41 PM | 19 hours ago |
| RSI: Oversold | 1:37 PM | 19 hours ago |
| MACD: Sell Signal | 1:18 PM | 19 hours ago |
| SMA: Bullish | 12:58 PM | 19 hours ago |
| MACD: Buy Signal | 12:50 PM | 20 hours ago |
| MACD: Sell Signal | 12:48 PM | 20 hours ago |
| MACD: Buy Signal | 12:36 PM | 20 hours ago |
| MACD: Sell Signal | 12:20 PM | 20 hours ago |
| MACD: Buy Signal | 12:17 PM | 20 hours ago |
Newest 20 of 31.
Analyst view
Consensus: hold
Hold
Price target (mean) 3.67 +42.7% upside
Now 2.57
- Target (low)
- 1.00
- Target (mean)
- 3.67
- Target (high)
- 8.00
Ratings (0m) 18 4 buy · 12 hold · 2 sell
- Strong buy0
- Buy4
- Hold12
- Sell0
- Strong sell2
Recommendation trend
- This month 18
- 1 month ago 19
- 2 months ago 19
- 3 months ago 19
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.3561 | -0.87 – 0.10 | -0.23 | -54.8% | 36.02M | -40.0% | 15 |
| Next quarter | -0.52731 | -0.83 – -0.33 | -0.76 | +30.6% | 808.71K | -28.7% | 8 |
| Current year | -2.68 | -3.20 – -2.20 | -2.02 | -32.5% | 43.36M | -44.5% | 15 |
| Next year | -1.50 | -3.31 – -0.17 | -2.68 | +44.1% | 20.87M | -51.9% | 15 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 16, 2024 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Dec 16, 2024 | JP Morgan | Downgrade | Neutral | Underweight |
| Dec 13, 2024 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Dec 13, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Dec 13, 2024 | Chardan Capital | Downgrade | Buy | Neutral |
| Dec 13, 2024 | Baird | Maintained | Outperform | Outperform |
| Dec 13, 2024 | Stifel | Downgrade | Buy | Hold |
| Dec 11, 2024 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Nov 5, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Nov 5, 2024 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Nov 5, 2024 | Stifel | Maintained | Buy | Buy |
| Nov 5, 2024 | Truist Securities | Maintained | Buy | Buy |
| Nov 5, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 5, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 23, 2024 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Oct 23, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Oct 22, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Sep 19, 2024 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Sep 17, 2024 | Jones Trading | Initiated | — | Buy |
| Aug 8, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 8, 2024 | Truist Securities | Maintained | Buy | Buy |
| Aug 8, 2024 | B of A Securities | Upgrade | Neutral | Buy |
| Jun 18, 2024 | Oppenheimer | Maintained | Perform | Perform |
| May 30, 2024 | Evercore ISI Group | Maintained | In-Line | In-Line |
| May 9, 2024 | Citigroup | Maintained | Buy | Buy |
| May 9, 2024 | Morgan Stanley | Upgrade | Underweight | Equal-Weight |
| May 9, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 29, 2024 | Citigroup | Maintained | Buy | Buy |
| Feb 29, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 27, 2024 | JP Morgan | Maintained | Neutral | Neutral |